These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 19802895)

  • 1. Recurrent copy number alterations in BRCA1-mutated ovarian tumors alter biological pathways.
    Leunen K; Gevaert O; Daemen A; Vanspauwen V; Michils G; De Moor B; Moerman P; Vergote I; Legius E
    Hum Mutat; 2009 Dec; 30(12):1693-702. PubMed ID: 19802895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline copy number variations in BRCA1-associated ovarian cancer patients.
    Yoshihara K; Tajima A; Adachi S; Quan J; Sekine M; Kase H; Yahata T; Inoue I; Tanaka K
    Genes Chromosomes Cancer; 2011 Mar; 50(3):167-77. PubMed ID: 21213370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
    Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL
    Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor status could modulate the genomic pattern in familial and sporadic breast cancer.
    Melchor L; Honrado E; Huang J; Alvarez S; Naylor TL; García MJ; Osorio A; Blesa D; Stratton MR; Weber BL; Cigudosa JC; Rahman N; Nathanson KL; Benítez J
    Clin Cancer Res; 2007 Dec; 13(24):7305-13. PubMed ID: 18094411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Brca1 and Brca2 proteins and tumor pathogenesis.
    Ingvarsson S
    Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
    Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
    Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas.
    Aghmesheh M; Edwards L; Clarke CL; Byth K; Katzenellenbogen BS; Russell PJ; Friedlander M; Tucker KM; de Fazio A
    Gynecol Oncol; 2005 Apr; 97(1):16-25. PubMed ID: 15790432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation analysis of the BRCA1 gene in ovarian cancers.
    Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA
    Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic changes in inherited and sporadic ovarian carcinomas by comparative genomic hybridization: extensive similarity except for a difference at chromosome 2q24-q32.
    Tapper J; Sarantaus L; Vahteristo P; Nevanlinna H; Hemmer S; Seppälä M; Knuutila S; Butzow R
    Cancer Res; 1998 Jul; 58(13):2715-9. PubMed ID: 9661879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines.
    Zanazzi C; Hersmus R; Veltman IM; Gillis AJ; van Drunen E; Beverloo HB; Hegmans JP; Verweij M; Lambrecht BN; Oosterhuis JW; Looijenga LH
    Genes Chromosomes Cancer; 2007 Oct; 46(10):895-908. PubMed ID: 17620293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD; Frank TS; Xu J; Pham TM; Calzone KA; Bennett-Baker P; Chamberlain J; Boyd J; Garber JE; Collins FS
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA array-based method for detection of large rearrangements in the BRCA1 gene.
    Frolov A; Prowse AH; Vanderveer L; Bove B; Wu H; Godwin AK
    Genes Chromosomes Cancer; 2002 Nov; 35(3):232-41. PubMed ID: 12353265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of TP53 and p21 in familial and sporadic ovarian cancer in Japan.
    Amikura T; Sekine M; Hirai Y; Fujimoto S; Hatae M; Kobayashi I; Fujii T; Nagata I; Ushijima K; Obata K; Suzuki M; Yoshinaga M; Umesaki N; Satoh S; Enomoto T; Motoyama S; Nishino K; Haino K; Tanaka K;
    Gynecol Oncol; 2006 Feb; 100(2):365-71. PubMed ID: 16337994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer.
    Tangir J; Muto MG; Berkowitz RS; Welch WR; Bell DA; Mok SC
    Oncogene; 1996 Feb; 12(4):735-40. PubMed ID: 8632895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of genes involved in squamous cell carcinoma of the lung using synchronized data from DNA copy number and transcript expression profiling analysis.
    Lo KC; Stein LC; Panzarella JA; Cowell JK; Hawthorn L
    Lung Cancer; 2008 Mar; 59(3):315-31. PubMed ID: 18029052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No differences in p53 mutation frequencies between BRCA1-associated and sporadic ovarian cancers.
    Aghmesheh M; Nesland JM; Kaern J; Dorum A; Edwards L; Byth K; Friedlander M; Jackson P; Tucker KM; Russell PJ
    Gynecol Oncol; 2004 Dec; 95(3):430-6. PubMed ID: 15581943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 and p53 protein expression in cultured ovarian surface epithelial cells derived from women with and without a BRCA1 germline mutation.
    Piek JM; Dorsman JC; Massuger LF; Ansink AC; Weegenaar J; Shvarts A; Kenemans P; Verheijen RH
    Arch Gynecol Obstet; 2006 Oct; 274(6):327-31. PubMed ID: 16826413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors.
    Assämäki R; Sarlomo-Rikala M; Lopez-Guerrero JA; Lasota J; Andersson LC; Llombart-Bosch A; Miettinen M; Knuutila S
    Genes Chromosomes Cancer; 2007 Jun; 46(6):564-76. PubMed ID: 17330260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p53 mutational spectrum associated with BRCA1 mutant ovarian cancer.
    Buller RE; Lallas TA; Shahin MS; Sood AK; Hatterman-Zogg M; Anderson B; Sorosky JI; Kirby PA
    Clin Cancer Res; 2001 Apr; 7(4):831-8. PubMed ID: 11309330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.